GWAS-related meQTLs across different cancer types
We identified 2,214,458 meQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
Cancer type
|
QTL type
|
tagSNP
|
Gene position (hg19)
|
Gene
|
p-value
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BLCA | trans | rs11098499 | 0.865 | rs4507344 | chr4:120307485 | C/A | cg19731845 | chr4:166199412 | KLHL2;GK3P | 0.35 | 6.2 | 0.3 | 1.5E-9 | Corneal astigmatism; |
BLCA | trans | rs561341 | 0.623 | rs4795665 | chr17:30233657 | C/T | cg20587970 | chr11:113659929 | NA | -0.83 | -12.56 | -0.54 | 1.67E-30 | Hip circumference adjusted for BMI; |
BLCA | trans | rs4889911 | 1 | rs4889910 | chr17:77839795 | C/T | cg02933969 | chr8:12612811 | LONRF1 | 0.43 | 6.1 | 0.3 | 2.62E-9 | Electroencephalogram traits; |
BLCA | trans | rs4889911 | 1 | rs4889910 | chr17:77839795 | C/T | cg05052031 | chr3:33138450 | TMPPE;GLB1 | 0.47 | 6.55 | 0.32 | 1.83E-10 | Electroencephalogram traits; |
BLCA | trans | rs4889911 | 1 | rs4889910 | chr17:77839795 | C/T | cg09399498 | chr7:86782128 | DMTF1 | 0.46 | 6.47 | 0.32 | 2.94E-10 | Electroencephalogram traits; |
BLCA | trans | rs4889911 | 1 | rs4889910 | chr17:77839795 | C/T | cg21691089 | chr1:8938721 | ENO1 | 0.43 | 6.15 | 0.3 | 2.02E-9 | Electroencephalogram traits; |
BLCA | trans | rs561341 | 1 | rs537166 | chr17:30326827 | C/T | cg27661571 | chr11:113659931 | NA | -0.51 | -6.26 | -0.31 | 1.05E-9 | Hip circumference adjusted for BMI; |
BLCA | trans | rs78049276 | 0.688 | rs61075980 | chr4:148374767 | G/A | cg13149281 | chr14:23389818 | RBM23;PRMT5 | -0.69 | -8.58 | -0.4 | 2.47E-16 | Pulse pressure; |
BLCA | trans | rs629535 | 0.814 | rs651985 | chr8:70054966 | G/A | cg21567404 | chr3:27674614 | NA | 0.87 | 14.46 | 0.6 | 4.76E-38 | Dupuytren's disease; |
BLCA | trans | rs629535 | 0.814 | rs72654071 | chr8:70079484 | A/G | cg21567404 | chr3:27674614 | NA | -0.87 | -14.43 | -0.59 | 6.31E-38 | Dupuytren's disease; |
BLCA | trans | rs11109072 | 0.655 | rs78546782 | chr12:98031173 | C/T | cg25564535 | chr2:98329463 | ZAP70 | -0.59 | -6.95 | -0.34 | 1.59E-11 | Obesity (early onset extreme); |
BLCA | trans | rs3780486 | 0.846 | rs7865745 | chr9:33140976 | A/G | cg04842962 | chr6:43655489 | MRPS18A | -1.07 | -28.16 | -0.82 | 4.68E-95 | IgG glycosylation; |
BLCA | trans | rs61931739 | 0.517 | rs7975714 | chr12:34055611 | T/C | cg13010199 | chr12:38710504 | ALG10B | 0.53 | 8.46 | 0.4 | 6.04E-16 | Morning vs. evening chronotype; |
BLCA | trans | rs208520 | 0.69 | rs851467 | chr6:66802721 | A/G | cg15611600 | chr13:45563400 | KIAA1704;NUFIP1 | -0.96 | -15.81 | -0.63 | 1.31E-43 | Exhaled nitric oxide output; |
BLCA | trans | rs2880058 | 0.521 | rs870939 | chr1:162004361 | A/G | cg24156658 | chr11:65122092 | TIGD3 | 0.39 | 6.02 | 0.3 | 4.0E-9 | QT interval; |